Insider Screener
Real-time Form 4 Filtering Engine
| Filing Date | Trade Date | Ticker | Company Name | Reporting Person | Relationship | Industry (by SEC) | Type | Price | Qty | Total, $ | Owned After | Change, % |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-02-26 03:59 | 2026-02-23 | VERA | Vera Therapeutics, Inc. | Grant Sean | Officer; CHIEF FINANCIAL OFFICER | Pharmaceutical Preparations | SALE | $41.98 | 4,949 | $207,778 | 114,181 | -4.2% |
| 2024-04-06 04:32 | 2024-04-03 | VERA | Vera Therapeutics, Inc. | Grant Sean | Officer; CHIEF FINANCIAL OFFICER | Pharmaceutical Preparations | OPT+S | $39.58 | 118,477 | $4,689,722 | 5,000 | -96.0% |
| 2023-06-23 23:05 | 2023-06-23 | VERA | Vera Therapeutics, Inc. | Grant Sean | Officer; Chief Financial Officer | Pharmaceutical Preparations | BUY | $16.60 | 5,000 | $83,000 | 5,992 | +504.0% |
| 2023-02-18 00:17 | 2023-02-06 | VERA | Vera Therapeutics, Inc. | Grant Sean | Officer; Chief Financial Officer | Pharmaceutical Preparations | BUY | $7.00 | 14,285 | $99,995 | 49,933 | +40.1% |
| 2023-02-09 00:04 | 2022-02-06 | VERA | Vera Therapeutics, Inc. | Grant Sean | Officer; Chief Financial Officer | Pharmaceutical Preparations | BUY | $7.00 | 14,285 | $99,995 | 49,933 | +40.1% |
| 2022-06-16 23:06 | 2022-06-15 | VERA | Vera Therapeutics, Inc. | Grant Sean | Officer; Chief Financial Officer | Pharmaceutical Preparations | BUY | $13.60 | 5,000 | $68,004 | 992 | +100.0% |
Strategic Signal Filtering
Our screener allows you to cut through the noise of routine stock grants and small trades. By focusing on high-value transactions from C-suite executives (CEO/CFO), you can identify where the "Smart Money" is being deployed with maximum conviction.
Investing Without Illusions
Insider data is not a magic wand, but it is the most honest indicator available. While insiders sell for many reasons (taxes, personal needs), they generally buy for only one: they believe the stock price is undervalued. We provide the tools to track these skin-in-the-game moves.
UNDERSTANDING THE DATA
FILING DATE: The date and time when the transaction was reported to the SEC. This is when the public first receives the information.
TRADE DATE: The actual day the insider executed the purchase or sale in the market.
INDUSTRY: The specific market sector the company operates in. Useful for identifying broader institutional capital flows across sectors.
OWNED AFTER: The total number of shares held by the insider following the transaction. This highlights the insider's remaining conviction in the company.
CHANGE %: The percentage increase or decrease of the insider's total position. Large percentage changes often carry more weight than the dollar amount alone.
TRADE TYPES DEFINITIONS
BUY: An open market purchase. Typically indicates an insider's belief that the stock is undervalued or poised for growth.
SELL: An open market sale. While often used for diversification or liquidity, large or unexpected sales can be a warning signal.
OPT+S (OPTION EXERCISE & SALE): This occurs when an insider exercises their stock options and sells them immediately. Often part of a structured compensation plan.